| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |